TM
First Quarter 2026 Earnings PresentationMay 7, 2026
Executive Summary
Strength at CompoSecure Offset by Market-Driven Weakness at Husky - Thesis Remains Intact
1Q performance
CompoSecure delivered record sales, strong operating performance, and continued margin expansion
Husky impacted by unanticipated market headwinds due to oil / resin price shock and continued tariff uncertainty
Market demand drivers
CompoSecure seeing robust demand from both traditional banks and leading fintechs
Husky faced demand deferrals as customers rapidly shifted to "wait-and-see" mode in second half of March
Revising full year 2026 guidance
Continued strong performance anticipated at CompoSecure
Cannot predict when transient demand headwinds abate for Husky, so being cautious with full year outlook
Committed to continued ROS deployment and strategic investments
CompoSecure one year ahead of Husky - see clear impact from high-performance culture and investments
ROS implementation focused on both growth and operations at CompoSecure and accelerating at Husky
3
1Q26 Financial PerformanceContinued Strength at CompoSecure Overshadowed by Market-Driven Weakness at Husky
PF Adjusted Net Sales1 ($mn)
PF Adjusted EBITDA ($mn)2,3
PF Adjusted EBITDA Margin2,3
▲
2.6%
$130.4
↑ 25.6%
$103.9
$306.8
$290.8
↓ 5.2%
▼
430bps
▼
(16.0%)
Husky / CompoSecure Husky / CompoSecure
$410.7 $421.2$97.73
23.8%
19.5%
$47.6
↑ 36.8%
$34.8
$38.2
↓ 40.2%
$63.9
$82.13
1Q25 1Q26
1Q25 1Q26
1Q25 1Q26
CompoSecure benefited from accelerating demand across both banks and fintechs
Husky faced market ambiguity from oil / resin price shock and continued tariff uncertainty creating demand delays
CompoSecure delivered significant EBITDA growth from higher sales and operational productivity gains
Husky decline due to lower sales, higher cost base than planned, and continued investments in R&D and front-end sales
CompoSecure margin expansion from ROS initiatives delivering improved manufacturing yields and operational efficiencies
Husky burdened by under absorbed labor costs, negative operating leverage, and one-time investments
ROS driven performance at CompoSecure offset by market-driven weakness at Husky
Note: For a reconciliation of Non-GAAP measures to the most directly comparable measures prepared in accordance with GAAP, please reference the Appendix.
Pro Forma Adjusted Net Sales include sales generated prior to the closing of the Husky transaction on January 12, 2026.
Pro Forma Adjusted EBITDA includes the management fees (collectively, "Management Fee") that would have been paid had the management agreements between Resolute Holdings and each of GPGI Holdings, L.L.C. (the "CompoSecure Management 4
Agreement") and Husky Holdings LLC (the "Husky Management Agreement", and together, the "Management Agreements") been in effect from January 1, 2025.
Pro Forma Adjusted EBITDA quarterly totals are inclusive of Corporate segment allocation. In 1Q25, Corporate Pro Forma Adjusted EBITDA was ($1.1mn). For 1Q26, Corporate Pro Forma Adjusted EBITDA was ($3.8mn).
Simplified, GAAP to Non-GAAP Operating Results
($ in millions)
GAAP Net Loss | ($235.0) |
Plus: Pro Forma impact of Husky Holdings (1/1-1/11) | ($18.0) |
Pro Forma Net Loss | ($253.0) |
Plus: Loss on extinguishment and refinancing of debt | 106.8 |
Plus: Husky transaction costs | 98.0 |
Plus: Depreciation and amortization | 63.7 |
Plus: Net interest expense | 36.7 |
Plus: Other items | 29.9 |
Pro Forma Adjusted EBITDA | $82.1 |
Simplified walk to Pro Forma Adjusted EBITDA given transaction and accounting complexity
Note: For a comprehensive reconciliation, please reference the 1Q26 Statement of Operations on page 16.
5
What Changed for Husky?Oil / Resin Price Shock Following 4Q25 Earnings Impacted 1Q26 Performance and FY26 Outlook
4Q25 Call
March
1Q26
So What?
Jan: +7% y/y Pipeline +4% y/y +4% y/y Feb: +6% y/y |
|
Jan: +32% y/y Orders -16% y/y +8% y/y Feb: +22% y/y |
|
Jan: -4% y/y Backlog -5% y/y -5% y/y Feb: +1% y/y |
|
Aftermarket Orders = Jan: +11% y/y Embedded Resiliency Feb: +26% y/y -11% y/y +6% y/y |
|
Other Factors
Positive: Oil / resin prices increasing customer focus on light weighting and upgrades, and further evaluation of rPET systems
Negative: Customer uncertainty driving lower end-of-quarter shipments vs. historical levels and continued "wait-and-see" behavior
Oil and resin price shock pushed out orders and deliveries
1. Numbers for periods beyond 1Q26 are estimates subject to change including in connection with normal quarter-end procedures.
6
Resilient End-Market Demand Impacted by Near-Term VolatilityShort-Term Disruption
Oil / Resin Price Shock Impacted Customer Purchases
Demand Remains Resilient
Non-Alcoholic Beverage Demand
Spike in PET Resin Prices ($ / tonne)
10.0%
8.0%
6.0%
4.0%
2.0%
0.0%
-2.0%
Apr-25 May-25 May-25 Jun-25 Jul-25 Aug-25 Sep-25 Oct-25 Nov-25 Dec-25 Jan-26 Feb-26 Mar-26
Apr-26
-4.0%
Volume Pricing Sales Growth
$1,929
$1,433
$1,620
US
+36% vs. Jan
Feb-26 Mar-26 Apr-26
Europe
+64% vs. Jan
$1,632 $1,701
$1,077
Feb-26 Mar-26 Apr-26
$860
China
+48% vs. Jan
$1,285 $1,205
Feb-26 Mar-26 Apr-26
Lightweighting - increased focus on
Long-Term Trends
Customer Focus on Productivity
lightweighting given PET is ~60-70% of the cost
Format Shifts - family / in-home packs, value-focused sizes, penetration of cheaper brands
Alternative Feedstocks - shift to rPET (similar price as virgin resin now) and bio-resins
Uptime & Throughput - focus on resin wastage, energy usage, and machine uptime to manage production economics
Asset Renewal - customer reevaluating their aging installed bases
Pipeline Remains Strong1
Customers Delay Orders2
Husky Differentiation
Y/Y Growth
+7%
+6%
+4%
+8%
103%
98%
98%
107%
Jan-26 Feb-26 Mar-26 Apr-26
32%
22% 2% | ||||
-16% | ||||
Jan-26 Feb-26 Mar-26 Apr-26
Husky has market leadership in lighter weight applications given higher precision
Recycled resins add more variability (viscosity, inclusions) - Husky has differentiated solutions to support up to 100% recycled PET
15-20% TCO advantage vs. competitors
Long track record of best-in-class uptime and throughput with continuous monitoring via Advantage+Elite service
Sources: NielsenIQ xAOC + C & Amazon and Wood Mackenzie.
Reflects growth in the 12-month opportunity pipeline, indexed starting in December 2025.
Represents year-over-year growth rates. 7
Oil / Resin Price Shock Delaying Demand
Pro Forma Adjusted Net Sales1 of $290.8 million down 5.2% compared to first quarter 2025, driven by declines in PET system sales and tooling offsetting strong growth in spare parts, hot runners, and controllers.
Pro Forma Adjusted EBITDA of $38.2 million down 40.2% compared to first quarter 20252, due to lower revenues with resulting negative operating leverage, and continued investments in R&D and sales.
Orders and backlog weakened quickly in late March with resin price shock; pipeline strength provides support for revenue growth and improved profitability in the second half of the year.
Focused on accelerating ROS implementation to establish a high-performance culture while making necessary investments to catalyze innovation and accelerate long-term organic growth.
Focused on disciplined execution, ROS implementation, and ongoing investment to scale the business
Note: For a reconciliation of Non-GAAP measures to the most directly comparable measures prepared in accordance with GAAP, please reference the Appendix.
Pro Forma Adjusted Net Sales include sales generated prior to the closing of the Husky transaction on January 12, 2026.
Pro Forma Adjusted EBITDA includes the Management Fee that would have been paid had the Management Agreements been in effect from January 1, 2025. 8
Market Environment by Product Line and Region
Product Line | 1H26 | FY26 | Key Drivers |
New Systems |
| ||
Aftermarket Tooling |
| ||
Hot Runners & Controllers |
| ||
Parts & Services |
|
Region | FY26 | Key Drivers |
North America |
| |
Europe, Middle East, Africa |
| |
Latin America |
| |
Asia Pacific |
|
9
1Q26 Financial Performance▼
770bps
Macroeconomic Demand Ambiguity Led to Revenue Decline and Margin Degradation
PF Adjusted Net Sales ($mn)1
PF Adjusted EBITDA ($mn)2
PF Adjusted EBITDA Margin2
▼
(5.2%)
$306.8
$290.8
▼
(40.2%)
$63.9
20.8%
$38.2
13.2%
1Q25 1Q26
1Q25 1Q26
1Q25 1Q26
Decline driven by customer demand delays and specific delivery problems caused by Middle East conflict, oil price shock, and continued tariff uncertainty
Over $20 million in revenue shifted out of the quarter due to customer deferrals, shipment delays in the Middle East, and delayed payments - trend continues in 2Q
Decline primarily attributable to lower revenue growth, under absorbed labor and fixed costs, and one-time strategic investments in R&D and front-end sales capabilities
Margin compression due to negative operating leverage and product mix
~250bps from under absorbed labor
~160bps from one-time growth investments
Remaining from negative operating leverage as revenues were pushed out
Margins expected to improve significantly through the year with improving fixed cost absorption and planned cost saving actions
Managing through demand uncertainty while continuing "seed planting" investments to position the business for growth and margin expansion
Note: For a reconciliation of Non-GAAP measures to the most directly comparable measures prepared in accordance with GAAP, please reference the Appendix.
Pro Forma Adjusted Net Sales include sales generated in the period in January prior to the closing of the Husky transaction on January 12, 2026.
Pro Forma Adjusted EBITDA includes the Management Fee that would have been paid had the Management Agreements been in effect from January 1, 2025. 10
Delivering Record Net Sales and Strong Operating Performance
Record Adjusted Net Sales of $130.4 million up 25.6% compared to first quarter 2025, driven by robust demand from traditional banks and leading fintechs.
Adjusted EBITDA of $47.6 million up 36.8% compared to first quarter 20251, due to organic revenue growth and continued operational efficiencies from ROS implementation.
Numerous high-profile card program wins include American Express Graphite, Robinhood Platinum, Intuit, Fold, MetaMask in the US, Kraken (debit), X Money (debit), and Revolut Audi F1 (debit).
Investments aligned to our strategic and execution framework include key leadership expansion with the appointment of General Managers for our International and Arculus businesses.
Record sales and strong operating leverage in the first quarter
Note: For a reconciliation of Non-GAAP measures to the most directly comparable measures prepared in accordance with GAAP, please reference the Appendix.
Pro Forma Adjusted EBITDA includes the Management Fee that would have been paid had the Management Agreements been in effect from January 1, 2025.
11
1Q26 Financial Performance▲
36.8%
Significant Progress Against All Key Metrics Catalyzed by ROS
Adjusted Net Sales ($mn)
Adjusted EBITDA ($mn)1
Adjusted EBITDA Margin1
▲
25.6%
$130.4
$47.6
$103.9
▲
300bps
36.5%
33.5%
$34.8
1Q25 1Q26
1Q25 1Q26
1Q25 1Q26
Driven by robust demand across both traditional banks and leading fintechs
Reinvigorated go-to-market with sales process training and sales enablement tools
Process innovation consistently improving manufacturing yields
Investment in engineering and manufacturing capabilities enhancing margins
Strong sales and margin expansion from ROS-enabled operating efficiency gains
Note: For a reconciliation of Non-GAAP measures to the most directly comparable measures prepared in accordance with GAAP, please reference the Appendix.
1. Pro Forma Adjusted EBITDA includes the Management Fee that would have been paid had the Management Agreements been in effect from January 1, 2025.
12
Introducing 2Q26 and Revising FY26 GuidanceFocused on Execution - Implementing ROS to Catalyze Growth and Improve Profitability
($ in millions)
Guidance Metrics | 2Q26 | FY261 |
Pro Forma Adjusted Net Sales2 | $425 - $475 (-9% y/y) | $1,950 - $2,100 (+0% y/y)2 |
Pro Forma Adjusted EBITDA2,3 | $105 - $120 (-14% y/y) | $550 - $610 (+7% y/y) |
Pro Forma Adjusted EBITDA Margin2,3 | 24.7% - 25.3% (-140bps) | 28.2% - 29.0% (+180bps) |
Pro Forma Adjusted Free Cash Flow4 | $275 - $325 |
Delay
Resolve
Iran? Oil? Tariffs?
GPGI Expectations
Flat organic revenue growth in FY26
CompoSecure to grow LDD driven by continued penetration of large, untapped addressable market
Husky to decline MSD driven by macro disruptions and demand softness in select regional markets
Margin expansion in second half of the year from organic sales growth, continued cost savings, and fixed cost leverage from ROS implementation
Healthy free cash flow with higher growth capital expenditures
Effectively mitigating tariff impacts through pricing and sourcing initiatives
Continued strong performance at CompoSecure expected to be offset by market-driven weakness at Husky
Note: For a reconciliation of Non-GAAP measures to the most directly comparable measures prepared in accordance with GAAP, please reference the Appendix.
Year-over-year growth rate based on midpoint of guidance ranges. For FY26, measures include pro forma effect of Husky for periods prior to the completion of the Husky acquisition on January 12, 2026.
Pro Forma Adjusted Net Sales for FY 2026 include sales generated prior to the closing of the Husky transaction on January 12, 2026. 13
Pro Forma Adjusted EBITDA includes the Management Fee that would have been paid had each of the Management Agreements been in effect from January 1, 2025.
FY26E Pro Forma Adjusted Free Cash Flow includes ~$45mn in one-time, growth capital expenditures across both CompoSecure and Husky and excludes one-time Husky transaction and debt refinancing costs.
Key Financial Metrics
($ in millions)
As of March 31, 2026 | |
Cash Balance | $122 |
Total Debt Outstanding1 | $2,175 |
Net Debt | $2,053 |
LTM Net Debt / Pro Forma Adjusted EBITDA2 | 3.7x |
Revolver Capacity3 | $322 |
Total Liquidity | $444 |
Credit Highlights
GPGI has no near-term maturities
$400mn revolver matures in 2031 (~5 years)
$1.2bn term loan and $900mn of senior secured notes both mature in 2033 (~7 years)
Term loan has annual amortization of $12mn - represents $3mn per quarter commencing in 3Q 2026 - with bullet payment at maturity (2033)
Debt instruments are all covenant lite
Non-GAAP year-end Net LTM leverage of approximately 3.0x
GPGI has ample liquidity and manageable leverage, with a continued focus on debt paydown
Note: For a reconciliation of Non-GAAP measures to the most directly comparable measures prepared in accordance with GAAP, please reference the Appendix.
Total debt outstanding includes term loan, senior secured notes, and drawn revolver.
Pro Forma Adjusted EBITDA includes the Management Fee that would have been paid had each of the Management Agreements been in effect from January 1, 2025. 14
Revolver capacity reflects undrawn revolver balance net of outstanding letters of credit.
Statement of Operations - 1Q26
Unaudited GAAP to Non-GAAP Operating Results
($ in millions)
Three Months Ended
March 31, 2026
GAAP
Pro Forma Non-GAAP
GPGI, Inc. (1/1 - 3/31)
Addition of
Husky Holdings (1/1-1/11)
Addition of
GPGI Holdings
Elimination of Equity
Method Investment
Net sales | - | - | $407.8 | $13.4 | $421.2 |
Cost of sales | - | - | 252.2 | 12.3 | 264.5 |
Gross profit Operating expenses: | - | - | 155.6 | 1.1 | 156.7 |
Research and development | - | - | 8.4 | - | 8.4 |
Selling, general and administrative expenses | 55.6 | - | 162.8 | 13.9 | 232.3 |
Foreign currency losses (gains) | - | - | (1.2) | (1.9) | (3.1) |
Income from operations | (55.6) | - | (14.4) | (10.9) | (80.9) |
Other (expense) income: | |||||
Revaluation of warrant liability | - | - | - | - | - |
Revaluation of earnout consideration liability | - | - | - | - | - |
Change in fair value of derivative liability | - | - | - | - | - |
Loss on remeasurement of TRA liability | (21.9) | - | - | - | (21.9) |
Interest expense | - | - | (29.4) | (7.1) | (36.5) |
Interest income | 0.2 | - | 0.2 | - | 0.4 |
Loss on extinguishment of debt | - | - | (106.8) | - | (106.8) |
Amortization of deferred financing costs | - | - | (0.5) | - | (0.5) |
Loss of sale of assets | - | - | - | - | - |
Total other income (expense), net | (21.7) | - | (136.5) | (7.1) | (165.3) |
Income (loss) before income taxes | (77.3) | - | (150.9) | (18.0) | (246.2) |
Income tax expense | (3.6) | - | (3.2) | - | (6.8) |
Earnings in GPGI Holdings L.L.C equity method investment | (154.1) | 154.1 | - | - | - |
Net Income (Loss) | ($235.0) | $154.1 | ($154.1) | ($18.0) | ($253.0) |
Add: | |||||
Depreciation and amortization | 63.7 | ||||
Income tax expense (benefit) | 6.8 | ||||
Interest expense, net (1) | 36.7 | ||||
Stock-based compensation | 5.2 | ||||
Husky transaction cost | 98.0 | ||||
Loss on extinguishment and refinancing of debts | 106.8 | ||||
Loss on remeasurement of TRA liability | 21.9 | ||||
Loss on sale of assets | 0.6 | ||||
FX (gain) loss | (4.2) | ||||
Severance costs | 0.6 | ||||
Incremental pro forma Management Fee | (1.0) | ||||
Pro Forma Adjusted EBITDA $82.1 | |||||
Note: The Non-GAAP columns represent a consolidation of the Company's results with those of GPGI Holdings, for consistency with prior consolidated presentation.
Includes amortization of deferred financing costs for the three months ended March 31, 2026.
16
Statement of Operations - 1Q25Unaudited GAAP to Non-GAAP Operating Results
($ in millions)
Three Months Ended March 31, 2025 | ||
GAAP | Equity Method Adjustments | Non-GAAP |
GPGI, Inc.
GAAP Results
Elimination of Equity Method Investment
Addition of GPGI Holdings
Adjusted March 31, 2025
Net sales | $59.8 | - | $44.1 | $103.9 |
Cost of sales | 31.1 | - | 18.3 | 49.4 |
Gross profit Operating expenses: | 28.7 | - | 25.8 | 54.5 |
Selling, general and administrative expenses | 22.7 | - | 10.1 | 32.8 |
Income from operations | 6.0 | - | 15.7 | 21.7 |
Other (expense) income: | ||||
Revaluation of warrant liability | 17.9 | - | - | 17.9 |
Revaluation of earnout consideration liability | 11.2 | - | - | 11.2 |
Interest expense | (1.6) | - | (1.7) | (3.3) |
Interest income | 0.2 | - | 0.9 | 1.1 |
Amortization of deferred financing costs | - | - | (0.1) | (0.1) |
Total other income (expense), net | 27.7 | - | (0.9) | 26.8 |
Income before income taxes | 33.7 | - | 14.8 | 48.5 |
Income tax (expense) benefit | (27.0) | - | - | (27.0) |
Earnings in CompoSecure Holdings L.L.C equity method investment | 14.8 | (14.8) | - | - |
Net Income (Loss) | $21.5 | ($14.8) | $14.8 | $21.5 |
Add: | ||||
Depreciation and amortization (3) | 2.3 | |||
Income tax expense (benefit) | 27.0 | |||
Interest expense, net (1) (3) | 2.4 | |||
Stock-based compensation | 5.7 | |||
Mark-to-market adjustments (2) | (29.2) | |||
Resolute spin-off costs | 5.0 | |||
Add back actual 1Q25 Management Fee for one month | 1.1 | |||
Add back expenses incurred on behalf of Resolute Holdings prior to Spin-Off | 1.0 | |||
Pro forma full quarter Management Fee | (3.2) | |||
Pro Forma Adjusted EBITDA | $33.7 |
Note: The Non-GAAP columns represent a consolidation of the Company's results with those of CompoSecure Holdings, for consistency with prior consolidated presentation.
Includes amortization of deferred financing costs for the three months ended March 31, 2025.
Includes the changes in fair value of warrant liability, derivative liabilities, and earnout consideration liability for the three months ended March 31, 2025. 17
The presented adjustments include amounts related to both CompoSecure and its equity method investment in Holdings.
Unaudited (GAAP and Non-GAAP)
($ in millions)
Three Months Ended March 31,
2026 | 2026 | ||
CASH FLOWS FROM OPERATING ACTIVITIES: | GAAP | Non-GAAP | |
Net income (loss) | ($235.0) | ($253.0) | |
Adjustments to reconcile net loss to net cash (used in) provided by operating activities Depreciation and amortization | - | 63.8 | |
Stock-based compensation expense | 2.0 | 5.3 | |
Earnings in equity method investment | 154.1 | - | |
Amortization of deferred financing costs Non-cash operating lease expense Revaluation of earnout consideration liability Revaluation of warrant liability Cash receipts from Holdings | - - - - - | 1.0 - - - - | |
Loss on remeasurement of TRA Liability | 21.9 | 21.9 | |
Loss on extinguishment of debt Non-cash interest on operating lease expense Loss/ (gain) on dispositions of property, plant and equipment and intangible assets Other Change in fair value of derivative liability | - - - - - | 66.3 - - 2.4 - | |
Deferred tax expense (benefit) | 13.7 | 4.0 | |
Changes in assets and liabilities | (9.3) | (65.5) | |
Net cash (used in) provided by operating activities | ($52.6) | ($153.8) | |
CASH FLOWS FROM INVESTING ACTIVITIES: | |||
Investment in GPGI Holdings | (2,016.8) | - | |
Cash used for acquisition | - | (762.2) | |
Purchase of property and equipment | - | (8.9) | |
Proceeds from sale of property and equipment and intangible assets | - | 0.2 | |
Acquisition of a business, net of cash and cash equivalents acquired | - | - | |
Maturities of short-term investments | - | 41.1 | |
Capitalized software expenditures | - | (4.3) | |
Resolute Holdings cash deconsolidated as a result of the Spin-Off GPGI Holdings cash deconsolidated as a result of the CompoSecure Management Agreement | - - | - - | |
Net cash used in investing activities | ($2,016.8) | ($734.1) | |
CASH FLOWS FROM FINANCING ACTIVITIES: | |||
Repayment of preference share capital Contributions from GPGI Inc Proceeds from employee stock purchase plan and exercise of options Payments for taxes related to net share settlement of equity awards | - - - - | (457.4) - -(26.6) | |
Debt issuance costs Payment of term loan | - - | (37.5) - | |
Proceeds from Revolver | - | 50.0 | |
Proceeds from issuance of common stock | 1,962.0 | 1,962.0 | |
Payment of debt, net of associated fees | - | (3,309.2) | |
Proceeds from issuance of long-term debt - net of discounts | - | 2,523.5 | |
Dividend to Class A shareholders Net cash obtained from PIPE Proceeds from the exercise of warrants | (0.7) - - | (0.7) - - | |
Net cash used in financing activities | $1,961.3 | $704.1 | |
Effect of exchange rate changes on cash and cash equivalents | - | (2.3) | |
Net increase (decrease) in cash and cash equivalents | (108.1) | (186.1) | |
Cash and cash equivalents, beginning of period | 114.6 | 307.7 | |
Cash and cash equivalents, end of period | $6.5 | $121.6 | |
Note: The Non-GAAP column represents a consolidation of the Company's results with those of GPGI Holdings L.L.C. ("GPGI Holdings"), for consistency with prior consolidated presentation.
Note: All instruments have been redeemed / exercised and no mark to market adjustments are expected going forward.
18
Balance SheetUnaudited (GAAP and Non-GAAP)
($ in millions)
GAAP
Non-GAAP
GAAP
Non-GAAP
March 31, 2026 March 31, 2026 December 31, 2025 December 31, 2025
ASSETS | ||||
CURRENT ASSETS Cash and cash equivalents | $6.5 | $121.6 | $114.6 | $271.6 |
Short-term investments | - | - | - | 41.1 |
Accounts receivable | - | 328.1 | - | 44.2 |
Inventories, net | - | 411.1 | - | 44.2 |
Prepaid expenses and other current assets | 16.4 | 38.0 | 5.5 | 8.6 |
Total Current Assets | $22.9 | $898.8 | $120.1 | $409.7 |
Property and equipment, net and right of use asset | - | $557.9 | - | $30.7 |
Deferred tax asset | 258.0 | 261.8 | 271.7 | 271.7 |
Intangible assets, net | - | 1,624.1 | - | - |
Goodwill | - | 3,041.9 | - | - |
Other assets | - | 48.1 | - | 4.0 |
Equity method investment | 3,133.2 | - | 125.5 | - |
Total Assets | $3,414.1 | $6,432.6 | $517.3 | $716.1 |
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||
CURRENT LIABILITIES Accounts payable | $1.4 | $101.8 | $0.8 | $12.7 |
Accrued expenses | 3.1 | 269.6 | 1.9 | 48.7 |
Deferred revenues | - | 164.8 | - | - |
Current portion of tax receivable agreement liability | 20.4 | 20.4 | 16.2 | 16.2 |
Current portion of long-term debt | - | 9.0 | - | 15.0 |
Other current liabilities | - | 56.3 | - | 5.8 |
Total Current Liabilities | $24.9 | $621.9 | $18.9 | $98.4 |
Long-term debt, net of deferred finance costs | - | 2,138.3 | - | 170.0 |
Deferred tax liability | - | 303.2 | - | - |
Tax receivable agreement liability | 272.9 | 272.9 | 255.2 | 255.2 |
Other liabilities | - | 62.7 | - | 7.3 |
Total Liabilities | $297.8 | $3,399.0 | $274.1 | $530.9 |
Stockholder's equity / (deficit) | 3,116.3 | 3,033.6 | 243.2 | 185.2 |
Total Liabilities and Stockholder's Equity / (Deficit) | $3,414.1 | $6,432.6 | $517.3 | $716.1 |
Finished 1Q26 with ~$122 million in cash
Note: The Non-GAAP columns represent a consolidation of the Company's results with those of GPGI Holdings, for consistency with prior consolidated presentation.
19
1Q26 Earnings Per Share and Adjusted Free Cash FlowNon-GAAP Reconciliation
($ in millions, except per share amounts)
Basic Earnings Per Share
Diluted Earnings Per Share
Three Months Ended March 31, 2026 2025
Net income (loss) ($235.0) $21.4
Add (less): Provision (benefit) for income taxes 6.8 27.0
Three Months Ended March 31, 2026 2025
Adjusted net income $32.7 $28.3
Add: Interest on Exchangeable Notes net of tax - -
Add (less): Mark-to-market adjustments (1) - (29.2)
Add: Stock-based compensation 3.9 5.7
Add: Debt refinance costs and loss on debt extinguishment 106.8 -
Adjusted net income used in computing net income per
share, diluted
Common shares outstanding used in computing earnings per share, diluted:
$32.7 $28.3
269,993,148 102,039,611
Add: Husky transactions costs 92.9 -
Add: Loss on remeasurement of TRA liability 21.9 -
Add: Foreign exchange (gain) loss (2.3) -
Add: Severance costs 0.6 -
Add: Loss on disposal of assets 0.6 -
Add: Spin-off costs - 5.0
Adjusted net income before tax | $43.0 | $29.9 |
Income tax expense (2) | 10.3 | 1.6 |
Add: Purchase accounting amortization and depreciation 46.8
Adjusted net income $32.7 $28.3
Common shares outstanding used in computing net income per share, basic:
Class A common shares 269,993,148 102,039,611
Warrants (3) - 9,878,000
Equity awards 4,391,631 3,533,000
Total shares outstanding used in computing adjusted
earnings per share - diluted
274,384,779
115,450,611
Adjusted net income per share - diluted $0.12 $0.25
Adjusted Free Cash Flow
Pro forma Non-GAAP cash from operations (4) ($153.8)
Pro forma Non-GAAP capital expenditures (including software) (4) (13.2)
Transaction and debt refinancing expenses paid (4) 196.0
Pro Forma Adjusted Free Cash Flow $29.0
Adjusted net income per share - basic $0.12 $0.28
Note: Non-GAAP EPS does not pro forma for period preceding the acquisition of Husky (January 1-11, 2026).
Includes the changes in fair value of warrant liability, make-whole provision of the previously outstanding exchangeable notes of GPGI Holdings (f/k/a CompoSecure Holdings, L.L.C.) (the "Exchangeable Notes") and earnout consideration liability.
Reflects current and deferred income tax expenses. For the three months ended March 31, 2026, it was calculated by applying the Company's assumed effective tax rate. 20
Applies treasury stock method with assumed exercise at average market price. No warrants were outstanding as of the three months ended March 31, 2026.
Reference 1Q26 Statement of Operations on page 16 and 1Q26 Statement of Cash Flows on page 18 for corresponding metrics.
| Attention: This is an excerpt of the original content. To continue reading it, access the original document here. |

